A later start for tumour screening has been proposed based on statistical models of the age‐dependent penetrance of SDHB mutations and, although the mean age in this cohort was relatively high, the youngest patient developed an HNPGL at age 11 years, and an 18‐year‐old patient had already developed PGL metastases. The gene discussed is SDHB; the disease is neoplasm.